HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SY
So-Young International Inc.
There isn't enough reported data to score SY yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Strong |
SY's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SY PE Valuation
SY has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SY Forward outlook
There aren't enough analyst estimates for SY to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over SY on earnings, with more consistent year-over-year improvement.
SY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.28 | +$0.46 |
| Q1 2026 | -$0.29 | +$0.39 |
| Q4 2025 | -$0.27 | +$0.39 |
| Q3 2025 | -$0.84 | -2200% |
| Q2 2025 | -$0.74 | -1950% |
| Q1 2025 | -$0.68 | -6900% |
| Q4 2024 | -$0.66 | -3400% |
| Q3 2024 | $0.04 | 0% |
SY lost $0.28 per share over the past year, a smaller loss than the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over SY on profitability, with a higher operating margin.
SY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $75.6M | +33% |
| Q1 2026 | $64.6M | +45% |
| Q4 2025 | $68.2M | +23% |
| Q3 2025 | $58M | +4% |
| Q2 2025 | $56.8M | -7% |
| Q1 2025 | $44.6M | -6.6% |
| Q4 2024 | $55.4M | -5.5% |
| Q3 2024 | $55.8M | -3.5% |
SY's revenue has grown year over year for four quarters in a row: $76M last quarter, up 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -8.6% | +3.8 points |
| Q1 2026 | -13% | +1.2 points |
| Q4 2025 | -22% | +140 points |
| Q3 2025 | -19% | -20 points |
| Q2 2025 | -12% | -14 points |
| Q1 2025 | -15% | -3 points |
| Q4 2024 | -162% | -161 points |
| Q3 2024 | 1.3% | +1.8 points |
SY's operating margin was −8.6% last quarter, up 3.8 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the stronger cash trend. Its trailing FCF is down 84% versus its history, compared with SY at down 1,200%.
SY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $0 | $0 |
| Q4 2025 | -$45.3M | -$45.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
| Q2 2024 | $0 | $0 |
SY's free cash flow was −$45M over the past year, against $0 the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +187K shares |
| 1 year | -0.1% | -75.7K shares |
| 3 years | +0.6% | +796K shares |
| 5 years | -6.3% | -8.9M shares |
| Available history | -6.2% | -8.6M shares |
SY has 131M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | $2.3M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -73.4x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -4.1x | Net Cash |
| Q1 2024 | -6.3x | Net Cash |
| Q4 2023 | -5.1x | Net Cash |
| Q3 2023 | -5.3x | Net Cash |
| Q2 2023 | -17.6x | Net Cash |
| Q1 2023 | -141.9x | Net Cash |
SY has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 12.9 | Oversold |
SY's weekly RSI is 40 (neutral) and its Stochastic is 13 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SY PE vs Healthcare Sector
| Metric | SY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SY has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.29 | 15% below |
| 20 week MA | $2.22 | 13% below |
| 50 week MA | $2.50 | 22% below |
| 100 week MA | $2.35 | 17% below |
| 200 week MA | $1.88 | 3.2% above |
SY has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
SY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.9 | $11.4 | -4.4% |
| 2021 | $11.4 | $3.13 | -73% |
| 2022 | $3.13 | $1.39 | -56% |
| 2023 | $1.39 | $1.29 | -7.2% |
| 2024 | $1.29 | $0.82 | -36% |
| 2025 | $0.82 | $2.63 | +221% |
| 2026 YTD | $2.63 | $1.94 | -26% |
SY has the edge over HIMS on returns for 2026, with the stronger performance.